Castle Biosciences: Meta-Analysis Showing DecisionDx-Melanoma Test as Independent, Significant Predictor of Recurrence and Metastatic Risk Presented during Late-Breaking Research Session at the 2019 AAD Annual Meeting

Press/Media

Period4 Mar 2019

Media coverage

1

Media coverage

  • TitleCastle Biosciences: Meta-Analysis Showing DecisionDx-Melanoma Test as Independent, Significant Predictor of Recurrence and Metastatic Risk Presented during Late-Breaking Research Session at the 2019 AAD Annual Meeting
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date4/03/19
    PersonsDarrell Rigel
View all 1
View less